Literature DB >> 17981813

Increased Gs signalling in platelets and impaired collagen activation, due to a defect in the dystrophin gene, result in increased blood loss during spinal surgery.

Veerle Labarque1, Kathleen Freson, Chantal Thys, Christine Wittevrongel, Marc F Hoylaerts, Rita De Vos, Nathalie Goemans, Chris Van Geet.   

Abstract

Controversy exists regarding the cause of the significantly increased blood loss during spinal surgery in Duchenne muscular dystrophy (DMD) patients compared with similar surgery in other patients. DMD is caused by a mutation in the cytoskeletal dystrophin, which binds to extracellular matrix laminin and which has been described as a G-protein-coupled receptor. We hypothesized that disturbed cytoskeleton organization in DMD patients would alter Gs protein and collagen signalling in platelets, leading to dysfunctional platelets and a haemorrhagic tendency during surgery. In the present study, we found that platelets and skin fibroblasts, respectively, express the Dp71 and Dp116 dystrophin isoforms. Absent or decreased expression of these isoforms in DMD patients correlates with significant Gs alpha upregulation. Moreover, dysfunctional dystrophin in these cells is accompanied with increased Gs signalling and higher cAMP levels after Gs stimulation. Functional analysis showed that DMD platelets responded slower to collagen with an extensive shape change in the aggregometer and with a significantly reduced platelet adhesion to coated collagen under flow. The decreased collagen activation was shown to result from both Gs activation and cytoskeletal disruption and not from decreased expression of platelet membrane receptors or impaired von Willebrand factor (vWF) activity. In conclusion, DMD platelets have a disorganized cytoskeleton and manifest Gs hyperactivity and reduced platelet collagen reactivity. Their increased bleeding during surgery will, at least partly, result from the increased platelet Gs activity after the release of natural Gs agonists as prostacyclin during surgery and an ineffective reactivity to collagen.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17981813     DOI: 10.1093/hmg/ddm312

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  7 in total

1.  Surgical treatment of Duchenne muscular dystrophy patients in Germany: the present situation.

Authors:  Jürgen Forst; Raimund Forst
Journal:  Acta Myol       Date:  2012-05

Review 2.  [Current care strategies for Duchenne muscular dystrophy].

Authors:  A Fujak; G Haaker; J Funk
Journal:  Orthopade       Date:  2014-07       Impact factor: 1.004

3.  Coagulation disorders in Duchenne muscular dystrophy? Results of a registry-based online survey.

Authors:  David C Schorling; Cornelia K Müller; Astrid Pechmann; Sabine Borell; Thorsten Langer; Simone Thiele; Maggie C Walter; Barbara Zieger; Janbernd Kirschner
Journal:  Acta Myol       Date:  2020-03-01

4.  Schwann cell-specific Dp116 is expressed in glioblastoma cells, revealing two novel DMD gene splicing patterns.

Authors:  Abdul Qawee Mahyoob Rani; Kazuhiro Maeta; Tatsuya Kawaguchi; Hiroyuki Awano; Masashi Nagai; Hisahide Nishio; Masafumi Matsuo
Journal:  Biochem Biophys Rep       Date:  2019-11-10

5.  Platelets of mice heterozygous for neurobeachin, a candidate gene for autism spectrum disorder, display protein changes related to aberrant protein kinase A activity.

Authors:  Kim Nuytens; Krizia Tuand; Michela Di Michele; Kurt Boonen; Etienne Waelkens; Kathleen Freson; John Wm Creemers
Journal:  Mol Autism       Date:  2013-11-04       Impact factor: 7.509

Review 6.  Corticosteroid Treatment Impact on Spinal Deformity in Duchenne Muscular Dystrophy.

Authors:  Ilaria Sanzarello; Luciano Merlini; Francesco Traina; Michele Attilio Rosa; Cesare Faldini
Journal:  Int Sch Res Notices       Date:  2014-10-29

Review 7.  Dystrophin Dp116: A yet to Be Investigated Product of the Duchenne Muscular Dystrophy Gene.

Authors:  Masafumi Matsuo; Hiroyuki Awano; Masaaki Matsumoto; Masashi Nagai; Tatsuya Kawaguchi; Zhujun Zhang; Hisahide Nishio
Journal:  Genes (Basel)       Date:  2017-10-02       Impact factor: 4.096

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.